Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) (ALLEGRO)
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
Demyelination: the role of reactive oxygen and nitrogen species.
Estimation of the effect of dalfampridine on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
UW-SES: A new self-efficacy scale for people with disabilities.
Progress in multiple sclerosis research in the last year.
Santhera receives first product approval: Health Canada approves Catena® for treatment of Friedreich's ataxia
MS related employment and disease modifying treatment in the German working population: 1994-2009.
Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
Assessment of the effect of interferon-beta1a therapy on thyroid and salivary gland functions in patients with multiple sclerosis using quantitative salivary gland scintigraphyz.
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.
Animal Models in Neurology: Drawbacks and Opportunities.
ATX-MS-1467, An Immunotolerizing Agent, Halts Disease Progression and Reduces CNS Inflammation in Rodent Models of Multiple Sclerosis (P1.216)
Multiple Sclerosis: Vitamin D and calcium as environmental determinants of prevalence (A Viewpoint)
Laquinimod in multiple sclerosis.
The value of specialty pharmaceuticals - a systematic review.
A telerehabilitation program by virtual reality-video games improves balance and postural control in multiple sclerosis patients.
Acute liver failure and liver transplantation in a patient with multiple sclerosis treated with interferon beta.
Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Glatiramer acetate (copaxone) modulates platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation.
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis.

Pages